Maha To Create 2,000 Prison Posts Amid Swelling Workload
Tired of too many ads? go ad free now
This raises the total sanctioned strength to 7,067, with 4,352 positions already filled and 2,715 currently under recruitment.This major administrative move was disclosed in an affidavit filed by principal secretary Radhika Rastogi before the Nagpur bench of Bombay high court recently in response to directives issued in a criminal writ petition filed by Nanded-based undertrial Sachin Lone through counsel Ratna Singh.To match upcoming prison infrastructure expansion, the additional director general and inspector general of prisons has proposed 2,097 additional posts for nine under-construction prisons. These roles will be filled after the new facilities are completed, in line with departmental policy.Among the newly sanctioned 2,000 posts are medical professionals such as doctors, psychologists, and psychiatrists, as well as technical support staff. The objective is to improve staff-to-inmate ratios and ensure smoother operations in a prison system currently operating at 149% occupancy.The affidavit outlines that recruitment is being carried out in phases, with a clear timeline for completion by the end of 2025. This drive includes filling vacancies for warders, assistant superintendents, clerks, and specialist medical staff."Prisons today require far more than basic supervision. The growing
, combined with rising medical and psychological needs, demands a comprehensive staffing policy," the affidavit observes.To further strengthen personnel presence, several steps are being taken to streamline postings and prevent overload in sensitive or high-pressure jails.
Special training modules are also being introduced for both new and existing prison staff, with emphasis on human rights, crisis response, and rehabilitation.Additionally, the govt approved proposals to appoint X-ray technicians, dentists, and physiotherapists at every central prison.
These positions will be created and filled in coordination with the public health department and district hospitals.The state reiterated its commitment to upholding standards set by the Supreme Court and other oversight agencies. "Strengthening manpower is crucial not just for managing prisons but for protecting inmate rights and reducing systemic stress," Rastogi stated in the affidavit.In a previous hearing, a division bench comprising justices Nitin Sambre and Vrushali Joshi flagged the systemic understaffing plaguing prisons, noting that "almost every prison in Maharashtra is overcrowded" and that in some facilities, "the number of inmates lodged is double the sanctioned capacity." It said this burden severely compromises prison administration and leads to delays in decision-making, especially on prisoners' applications.INFOStaffing Expansion Overview- New Posts Sanctioned: 2,000- Total Sanctioned Strength: 7,067- Currently Filled: 4,352- Vacancies Under Recruitment: 2,715- Shortfall Remaining: ~15% will still remain after current recruitment- Timeline: All ongoing recruitment to be completed by end of 2025Staffing for New Prisons- Proposed Additional Posts: 2,097- Purpose: To staff 9 under-construction prisons- Recruitment Phase: To begin post-completion of new jailsSpecialized Positions Sanctioned- Doctors- Psychologists- Psychiatrists- X-ray Technicians- Dentists- Physiotherapists- Technical Support Staff(To be appointed in coordination with Public Health Dept & District Hospitals)Operational Enhancements- Improved Staff-to-Inmate Ratios- Special Training Modules for new & current staff- Focus on Human rights, crisis response, & rehabilitation- Postings restructured to reduce burden on sensitive/high-pressure prisonsCourt Observations- Occupancy Status: 149%- Systemic Staffing Gap: 40% shortfall in sanctioned strength- Concern: Overcrowding & understaffing hampers prison administration- Bench Note: Only 25% of total vacancies being addressed in this drive
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Glenmark, Alembic Pharma, Sun Pharma recall drugs in US, says USFDA
Drug makers Glenmark, Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator. Mumbai-based Glenmark is recalling two products in the market, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, is recalling Carvedilol tablets, used to treat heart failure, hypertension, and heart attack, in multiple strengths. The New Jersey-based firm is recalling 55,560 units of the affected lot due to "presence of a nitrosamine, N-Nitroso Carvedilol impurity above the current acceptable intake level," the USFDA stated. The company is also recalling 17,496 bottles of Carvedilol tablets as "results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm," it added. Glenmark initiated the Class II recall in August this year. USFDA said the company is also recalling 22,656 bottles of Theophylline extended-release tablets (400 mg) for failed dissolution specifications. Alembic Pharmaceuticals is recalling 9,492 bottles of Doxepin Hydrochloride capsules, used in the treatment of insomnia, the US health regulator stated. The Class II recall is due to the "Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit," it said. The company initiated the recall on July 25 this year. New Jersey-based Sun Pharmaceutical Industries Inc is recalling 11,328 bottles of Spironolactone Tablets, used to treat high blood pressure, due to "Presence of foreign substance: identified as aluminum," the regulator said. The company commenced the Class II recall on August 5. As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
Business Standard
an hour ago
- Business Standard
Pancha Kosha: India's First Dedicated Aerial Art and Yoga School in Rishikesh
VMPL Rishikesh (Uttarakhand) [India], August 18: Pancha Koshas Aerial Art and Yoga School has developed as India's exclusive aerial yoga and aerial art school. This Rishikesh-based art school next to Secret Garden Cafe in Tapovan, is dedicatedly teaching aerial-based yoga courses, drifting from the traditional mat yoga to offer training suspended in silk hammocks. Founder Sagar Kinare spent years in wellness and movement before launching this aerial-only school. His decision came from personal practice and a belief that aerial yoga could unlock deeper transformation. "Aerial yoga came into my life during an injury when traditional yoga wasn't enough. That first class gave me freedom, strength, and clarity I hadn't found elsewhere. It planted the seed for Pancha Koshas, a space where healing meets movement, and discipline meets creativity through aerial arts," shares Sagar Kinare, Founder of Pancha Koshas. The school's name draws from yogic philosophy -- the five koshas represent physical, energetic, mental, intuitive, and blissful layers of human existence. "We guide people to explore these layers through aerial practice, helping them reconnect with their essence while suspended in silk," says Sagar. Sagar further points out, "Online aerial yoga practices can seem tough, through our courses, we try to close the gap between taking the first step that leads to more professional practices, with practice and time. Pancha Koshas teaches only aerial courses, unlike other yoga schools that mix different styles. Students learn aerial psychology and aerial-specific anatomy, subjects that are not taught elsewhere in India. The school provides more teaching and practice hours than competitors, with programs ranging from daily workshops to multi-level teacher training and specialized Aerial Yin sessions -- approaching aerial yoga as a form of art. Pancha Koshas requires graduates to practice for three months after training before receiving certification. This extra step ensures students are truly prepared to teach, contrasting with other programs that certify immediately. Professional equipment and strict safety protocols support this commitment to quality instruction. Faculty members work solely in aerial yoga, bringing focused expertise to each class. All instructors hold aerial-specific certifications and anatomical training. Classes accommodate different skill levels through modifications and progressive teaching methods. "We're creating India's first aerial community while honoring yoga's spiritual roots," Sagar explains. "We are not building performers. We are cultivating conscious movers. Through Pancha Koshas, our vision is to grow aerial education across India and the world, one breath, one student, one flight at a time."
Time of India
2 hours ago
- Time of India
Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA
Drug makers Glenmark , Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator. Independence Day 2025 Modi signals new push for tech independence with local chips Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji Subhas Chandra Bose gave India its own currency Mumbai-based Glenmark is recalling two products in the market, the US Food and Drug Administration ( USFDA ) said in its latest Enforcement Report. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, is recalling Carvedilol tablets, used to treat heart failure, hypertension, and heart attack, in multiple strengths. The New Jersey-based firm is recalling 55,560 units of the affected lot due to "presence of a nitrosamine, N-Nitroso Carvedilol impurity above the current acceptable intake level," the USFDA stated. The company is also recalling 17,496 bottles of Carvedilol tablets as "results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm," it added. Live Events Glenmark initiated the Class II recall in August this year. USFDA said the company is also recalling 22,656 bottles of Theophylline extended-release tablets (400 mg) for failed dissolution specifications. Alembic Pharmaceuticals is recalling 9,492 bottles of Doxepin Hydrochloride capsules, used in the treatment of insomnia, the US health regulator stated. The Class II recall is due to the "Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit," it said. The company initiated the recall on July 25 this year. New Jersey-based Sun Pharmaceutical Industries Inc is recalling 11,328 bottles of Spironolactone Tablets, used to treat high blood pressure, due to "Presence of foreign substance: identified as aluminum," the regulator said. The company commenced the Class II recall on August 5. As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
